{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:15:27Z","timestamp":1793488527520,"version":"4.5.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/nrdp.2016.47","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T04:46:47Z","timestamp":1467866807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":834,"title":["Sj\u00f6gren syndrome"],"prefix":"10.1038","volume":"2","author":[{"given":"Pilar","family":"Brito-Zer\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Sivils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"BFnrdp201647_CR1","doi-asserted-by":"publisher","first-page":"e3821","DOI":"10.1136\/bmj.e3821","volume":"344","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals, M., Brito-Zer\u00f3n, P., Sis\u00f3-Almirall, A. & Bosch, X. Primary Sj\u00f6gren syndrome. BMJ 344, e3821 (2012).","journal-title":"BMJ"},{"key":"BFnrdp201647_CR2","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/art.20093","volume":"50","author":"MN Manoussakis","year":"2004","unstructured":"Manoussakis, M. N. et al. Sj\u00f6gren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sj\u00f6gren's syndrome. Arthritis Rheum. 50, 882\u2013891 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"C Vitali","year":"1993","unstructured":"Vitali, C. et al. Preliminary criteria for the classification of Sj\u00f6gren's syndrome. Results of a prospective concerted action supported by the European Commununity. Arthritis Rheum. 36, 340\u2013347 (1993).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR4","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin, B. et al. Epidemiology of primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis. Ann. Rheum. Dis. 74, 1983\u20131989 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2014.931457","volume":"44","author":"M Kvarnstrom","year":"2015","unstructured":"Kvarnstrom, M., Ottosson, V., Nordmark, B. & Wahren-Herlenius, M. Incident cases of primary Sj\u00f6gren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Scand. J. Rheumatol. 44, 135\u2013142 (2015).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrdp201647_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3899\/jrheum.100883","volume":"38","author":"M-Y Weng","year":"2011","unstructured":"Weng, M.-Y., Huang, Y.-T., Liu, M.-F. & Lu, T.-H. Incidence and mortality of treated primary Sj\u00f6gren's syndrome in Taiwan: a population-based study. J. Rheumatol. 38, 706\u2013708 (2011).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.22115","volume":"66","author":"C Maldini","year":"2014","unstructured":"Maldini, C. et al. Epidemiology of primary Sj\u00f6gren's syndrome in a French multiracial\/multiethnic area. Arthritis Care Res. (Hoboken) 66, 454\u2013463 (2014).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/03009740600759704","volume":"35","author":"Y Kabasakal","year":"2006","unstructured":"Kabasakal, Y. et al. The prevalence of Sj\u00f6gren's syndrome in adult women. Scand. J. Rheumatol. 35, 379\u2013383 (2006).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrdp201647_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2015.03.008","volume":"14","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals, M. et al. Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun. Rev. 14, 670\u2013679 (2015).","journal-title":"Autoimmun. Rev."},{"key":"BFnrdp201647_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ajo.2015.06.004","volume":"160","author":"PM Mathews","year":"2015","unstructured":"Mathews, P. M. et al. Ocular complications of primary Sj\u00f6gren syndrome in men. Am. J. Ophthalmol. 160, 447\u2013452.e1 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrdp201647_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals, M. et al. Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87, 210\u2013219 (2008).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrdp201647_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/0009922807301945","volume":"46","author":"M Civilibal","year":"2007","unstructured":"Civilibal, M. et al. A child with primary Sj\u00f6gren syndrome and a review of the literature. Clin. Pediatr. (Phila.) 46, 738\u2013742 (2007).","journal-title":"Clin. Pediatr. (Phila.)"},{"key":"BFnrdp201647_CR13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3899\/jrheum.131511","volume":"41","author":"N Yokogawa","year":"2014","unstructured":"Yokogawa, N. et al. Comparison of labial minor salivary gland biopsies from childhood Sj\u00f6gren syndrome and age-matched controls. J. Rheumatol. 41, 1178\u20131182 (2014).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3899\/jrheum.090804","volume":"37","author":"AN Baer","year":"2010","unstructured":"Baer, A. N., Maynard, J. W., Shaikh, F., Magder, L. S. & Petri, M. Secondary Sj\u00f6gren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J. Rheumatol. 37, 1143\u20131149 (2010).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/RHU.0b013e31823ecbdf","volume":"18","author":"Q Yao","year":"2012","unstructured":"Yao, Q., Altman, R. D. & Wang, X. Systemic lupus erythematosus with Sj\u00f6gren syndrome compared to systemic lupus erythematosus alone: a meta-analysis. J. Clin. Rheumatol. 18, 28\u201332 (2012).","journal-title":"J. Clin. Rheumatol."},{"key":"BFnrdp201647_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/rheumatology\/39.6.603","volume":"39","author":"A Young","year":"2000","unstructured":"Young, A. et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford) 39, 603\u2013611 (2000).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/ard.62.9.897","volume":"62","author":"L Carmona","year":"2003","unstructured":"Carmona, L. et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann. Rheum. Dis. 62, 897\u2013900 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3899\/jrheum.090815","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac, J. et al. Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. J. Rheumatol. 37, 608\u2013614 (2010).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","volume":"75","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n, P. et al. Systemic activity and mortality inprimary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann. Rheum. Dis. 75, 348\u2013355 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","volume":"39","author":"AG Tzioufas","year":"2012","unstructured":"Tzioufas, A. G., Kapsogeorgou, E. K. & Moutsopoulos, H. M. Pathogenesis of Sj\u00f6gren's syndrome: what we know and what we should learn. J. Autoimmun. 39, 4\u20138 (2012).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1586\/1744666X.2014.878650","volume":"10","author":"MR Hillen","year":"2014","unstructured":"Hillen, M. R., Ververs, F. A., Kruize, A. A. & Van Roon, J. A. Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sj\u00f6gren's syndrome. Expert Rev. Clin. Immunol. 10, 521\u2013531 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrdp201647_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/clin.1994.1123","volume":"72","author":"HM Moutsopoulos","year":"1994","unstructured":"Moutsopoulos, H. M. Sj\u00f6gren's syndrome: autoimmune epithelitis. Clin. Immunol. Immunopathol. 72, 162\u2013165 (1994). This article dissects the main mechanisms on which the previously most-accepted hypothesis of SjS aetiopathogenesis was formed.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFnrdp201647_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000135622","volume":"15","author":"AG Tzioufas","year":"2008","unstructured":"Tzioufas, A. G., Tsonis, J. & Moutsopoulos, H. M. Neuroendocrine dysfunction in Sj\u00f6gren's syndrome. Neuroimmunomodulation 15, 37\u201345 (2008).","journal-title":"Neuroimmunomodulation"},{"key":"BFnrdp201647_CR24","first-page":"3","volume":"116","author":"RI Fox","year":"2002","unstructured":"Fox, R. I. & Stern, M. Sj\u00f6gren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand. J. Rheumatol. Suppl. 116, 3\u201313 (2002).","journal-title":"Scand. J. Rheumatol. Suppl."},{"key":"BFnrdp201647_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","volume":"35","author":"MN Manoussakis","year":"2010","unstructured":"Manoussakis, M. N. & Kapsogeorgou, E. K. The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren's syndrome. J. Autoimmun. 35, 219\u2013224 (2010).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","volume":"9","author":"G Nocturne","year":"2013","unstructured":"Nocturne, G. & Mariette, X. Advances in understanding the pathogenesis of primary Sj\u00f6gren's syndrome. Nat. Rev. Rheumatol. 9, 544\u2013556 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrdp201647_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2013.11.003","volume":"51","author":"Y-Z Gong","year":"2014","unstructured":"Gong, Y.-Z. et al. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sj\u00f6gren's syndrome. J. Autoimmun. 51, 57\u201366 (2014).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR28","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2174\/138920112802273100","volume":"13","author":"P Youinou","year":"2012","unstructured":"Youinou, P., Saraux, A. & Pers, J.-O. B-lymphocytes govern the pathogenesis of Sj\u00f6gren's syndrome. Curr. Pharm. Biotechnol. 13, 2071\u20132077 (2012).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"BFnrdp201647_CR29","doi-asserted-by":"crossref","unstructured":"Morva, A. et al. Salivary gland epithelial cells (SGECs) promote the differentiation of B cells. Presented at the 12th International Symposium on Sj\u00f6gren's Syndrome (2013).","DOI":"10.1136\/annrheumdis-2013-eular.284"},{"key":"BFnrdp201647_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/cei.12432","volume":"178","author":"NC Kyriakidis","year":"2014","unstructured":"Kyriakidis, N. C. et al. Toll-like receptor 3 stimulation promotes Ro52\/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway. Clin. Exp. Immunol. 178, 548\u2013560 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrdp201647_CR31","doi-asserted-by":"publisher","first-page":"17609","DOI":"10.1073\/pnas.1209724109","volume":"109","author":"JC Hall","year":"2012","unstructured":"Hall, J. C. et al. Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc. Natl Acad. Sci. USA 109, 17609\u201317614 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrdp201647_CR32","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/art.23214","volume":"58","author":"CQ Nguyen","year":"2008","unstructured":"Nguyen, C. Q., Hu, M. H., Li, Y., Stewart, C. & Peck, A. B. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sj\u00f6gren's syndrome: findings in humans and mice. Arthritis Rheum. 58, 734\u2013743 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/art.27318","volume":"62","author":"A Bikker","year":"2010","unstructured":"Bikker, A. et al. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sj\u00f6gren's syndrome correlates with increased inflammation. Arthritis Rheum. 62, 969\u2013977 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR34","doi-asserted-by":"publisher","first-page":"e77605","DOI":"10.1371\/journal.pone.0077605","volume":"8","author":"J-O Jin","year":"2013","unstructured":"Jin, J.-O., Shinohara, Y. & Yu, Q. Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sj\u00f6gren's syndrome in a mouse model. PLoS ONE 8, e77605 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrdp201647_CR35","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/art.38007","volume":"65","author":"J-O Jin","year":"2013","unstructured":"Jin, J.-O., Kawai, T., Cha, S. & Yu, Q. Interleukin-7 enhances the Th1 response to promote the development of Sj\u00f6gren's syndrome-like autoimmune exocrinopathy in mice. Arthritis Rheum. 65, 2132\u20132142 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR36","doi-asserted-by":"crossref","first-page":"243723","DOI":"10.1155\/2015\/243723","volume":"2015","author":"A Alunno","year":"2015","unstructured":"Alunno, A. et al. T regulatory and T helper 17 cells in primary Sj\u00f6gren's syndrome: facts and perspectives. Mediators Inflamm. 2015, 243723 (2015).","journal-title":"Mediators Inflamm."},{"key":"BFnrdp201647_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/sarh.2003.50019","volume":"33","author":"P Manganelli","year":"2003","unstructured":"Manganelli, P. & Fietta, P. Apoptosis and Sj\u00f6gren syndrome. Semin. Arthritis Rheum. 33, 49\u201365 (2003).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrdp201647_CR38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2012.11.016","volume":"38","author":"A Okuma","year":"2013","unstructured":"Okuma, A. et al. Enhanced apoptosis by disruption of the STAT3\u2013I\u03baB-\u03b6 signaling pathway in epithelial cells induces Sj\u00f6gren's syndrome-like autoimmune disease. Immunity 38, 450\u2013460 (2013).","journal-title":"Immunity"},{"key":"BFnrdp201647_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/1744666X.2014.892417","volume":"10","author":"D Lucchesi","year":"2014","unstructured":"Lucchesi, D., Pitzalis, C. & Bombardieri, M. EBV and other viruses as triggers of tertiary lymphoid structures in primary Sj\u00f6gren's syndrome. Expert Rev. Clin. Immunol. 10, 445\u2013455 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrdp201647_CR40","first-page":"1511","volume":"149","author":"S Wen","year":"1996","unstructured":"Wen, S. et al. Association of Epstein\u2013Barr virus (EBV) with Sj\u00f6gren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am. J. Pathol. 149, 1511\u20131517 (1996).","journal-title":"Am. J. Pathol."},{"key":"BFnrdp201647_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","volume":"51","author":"S Kivity","year":"2014","unstructured":"Kivity, S. et al. Infection and autoimmunity in Sj\u00f6gren's syndrome: a clinical study and comprehensive review. J. Autoimmun. 51, 17\u201322 (2014).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0166-0934(88)90051-1","volume":"21","author":"P Biberfeld","year":"1988","unstructured":"Biberfeld, P. et al. Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders. J. Virol. Methods 21, 49\u201359 (1988).","journal-title":"J. Virol. Methods"},{"key":"BFnrdp201647_CR43","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/art.1780331122","volume":"33","author":"C Baboonian","year":"1990","unstructured":"Baboonian, C., Venables, P. J., Maini, R. N., Kangro, H. O. & Osman, H. K. Antibodies to human herpesvirus-6 in Sj\u00f6gren's syndrome. Arthritis Rheum. 33, 1749\u20131750 (1990).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR44","first-page":"2065","volume":"26","author":"K Iakimtchouk","year":"1999","unstructured":"Iakimtchouk, K., Myrmel, H. & Jonsson, R. Serological screening for hepatitis B and C and human herpesvirus 6 in Norwegian patients with primary Sj\u00f6gren's syndrome. J. Rheumatol. 26, 2065\u20132066 (1999).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR45","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(94)90630-0","volume":"344","author":"K Terada","year":"1994","unstructured":"Terada, K. et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sj\u00f6gren's syndrome. Lancet 344, 1116\u20131119 (1994).","journal-title":"Lancet"},{"key":"BFnrdp201647_CR46","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/art.39009","volume":"67","author":"H Nakamura","year":"2015","unstructured":"Nakamura, H. et al. Direct infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sj\u00f6gren's syndrome. Arthritis Rheumatol. 67, 1096\u20131106 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/ard.56.3.173","volume":"56","author":"M Garc\u00eda-Carrasco","year":"1997","unstructured":"Garc\u00eda-Carrasco, M. et al. Hepatitis C virus infection in primary Sj\u00f6gren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann. Rheum. Dis. 56, 173\u2013175 (1997).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0140-6736(92)91645-O","volume":"339","author":"J Haddad","year":"1992","unstructured":"Haddad, J. et al. Lymphocytic sialadenitis of Sj\u00f6gren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339, 321\u2013323 (1992).","journal-title":"Lancet"},{"key":"BFnrdp201647_CR49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13075-015-0766-3","volume":"17","author":"P Brito-Zer\u00f3n","year":"2015","unstructured":"Brito-Zer\u00f3n, P. et al. How hepatitis C virus modifies the immunological profile of Sj\u00f6gren syndrome: analysis of 783 patients. Arthritis Res. Ther. 17, 250 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrdp201647_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1365-3083.1996.d01-2.x","volume":"43","author":"LR Haaheim","year":"1996","unstructured":"Haaheim, L. R. et al. Serum antibodies from patients with primary Sj\u00f6gren's syndrome and systemic lupus erythematosus recognize multiple epitopes on the La(SS-B) autoantigen resembling viral protein sequences. Scand. J. Immunol. 43, 115\u2013121 (1996).","journal-title":"Scand. J. Immunol."},{"key":"BFnrdp201647_CR51","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/art.39204","volume":"67","author":"JC Hall","year":"2015","unstructured":"Hall, J. C. et al. Molecular subsetting of interferon pathways in Sj\u00f6gren's syndrome. Arthritis Rheumatol. 67, 2437\u20132446 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR52","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1001\/jama.2013.278448","volume":"310","author":"R Jonsson","year":"2013","unstructured":"Jonsson, R. Autoantibodies present before symptom onset in primary Sj\u00f6gren syndrome. JAMA 310, 1854\u20131855 (2013). This study provides the first evidence showing that SjS-related autoantibodies might be detected several years before the diagnosis of the disease.","journal-title":"JAMA"},{"key":"BFnrdp201647_CR53","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/art.39214","volume":"67","author":"E Theander","year":"2015","unstructured":"Theander, E. et al. Prediction of Sj\u00f6gren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling. Arthritis Rheumatol. 67, 2427\u20132436 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR54","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1136\/ard.2010.142109","volume":"69","author":"L Klareskog","year":"2010","unstructured":"Klareskog, L., Gregersen, P. K. & Huizinga, T. W. J. Prevention of autoimmune rheumatic disease: state of the art and future perspectives. Ann. Rheum. Dis. 69, 2062\u20132066 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/joim.12346","volume":"278","author":"E Bartoloni","year":"2015","unstructured":"Bartoloni, E. et al. Cardiovascular disease risk burden in primary Sj\u00f6gren's syndrome: results of a population-based multicentre cohort study. J. Intern. Med. 278, 185\u2013192 (2015).","journal-title":"J. Intern. Med."},{"key":"BFnrdp201647_CR56","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/0961203310367504","volume":"19","author":"M P\u00e9rez-De-Lis","year":"2010","unstructured":"P\u00e9rez-De-Lis, M. et al. Cardiovascular risk factors in primary Sj\u00f6gren's syndrome: a case\u2013control study in 624 patients. Lupus 19, 941\u2013948 (2010).","journal-title":"Lupus"},{"key":"BFnrdp201647_CR57","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3109\/s10165-011-0446-3","volume":"21","author":"G Karabulut","year":"2011","unstructured":"Karabulut, G. et al. Cigarette smoking in primary Sj\u00f6gren's syndrome: positive association only with ANA positivity. Mod. Rheumatol. 21, 602\u2013607 (2011).","journal-title":"Mod. Rheumatol."},{"key":"BFnrdp201647_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/ard.59.1.54","volume":"59","author":"R Manthorpe","year":"2000","unstructured":"Manthorpe, R. et al. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA\/Ro and anti-SSB\/La antibodies in Sj\u00f6gren's syndrome? Ann. Rheum. Dis. 59, 54\u201360 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR59","doi-asserted-by":"publisher","first-page":"748","DOI":"10.7326\/0003-4819-101-6-748","volume":"101","author":"JD Reveille","year":"1984","unstructured":"Reveille, J. D., Wilson, R. W., Provost, T. T., Bias, W. B. & Arnett, F. C. Primary Sj\u00f6gren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann. Intern. Med. 101, 748\u2013756 (1984).","journal-title":"Ann. Intern. Med."},{"key":"BFnrdp201647_CR60","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/art.39127","volume":"67","author":"C-F Kuo","year":"2015","unstructured":"Kuo, C.-F. et al. Familial risk of Sj\u00f6gren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study. Arthritis Rheumatol. 67, 1904\u20131912 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR61","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.2792","volume":"45","author":"CJ Lessard","year":"2013","unstructured":"Lessard, C. J. et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren's syndrome. Nat. Genet. 45, 1284\u20131292 (2013). This is a key study about the complex genetic landscape of SjS.","journal-title":"Nat. Genet."},{"key":"BFnrdp201647_CR62","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ng.2779","volume":"45","author":"Y Li","year":"2013","unstructured":"Li, Y. et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren's syndrome at 7q11.23. Nat. Genet. 45, 1361\u20131365 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrdp201647_CR63","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/art.11103","volume":"48","author":"J-E Gottenberg","year":"2003","unstructured":"Gottenberg, J.-E. et al. In primary Sj\u00f6gren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheumatol. 48, 2240\u20132245 (2003).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR64","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12016-007-8002-9","volume":"32","author":"PH Williams","year":"2007","unstructured":"Williams, P. H. et al. Horizons in Sj\u00f6gren's syndrome genetics. Clin. Rev. Allergy Immunol. 32, 201\u2013209 (2007).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrdp201647_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.13192","volume":"168","author":"G Nocturne","year":"2015","unstructured":"Nocturne, G. & Mariette, X. Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management. Br. J. Haematol. 168, 317\u2013327 (2015). This article reviews the aetiopathogenetic mechanisms and clinical management of SjS-related lymphoma.","journal-title":"Br. J. Haematol."},{"key":"BFnrdp201647_CR66","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","volume":"122","author":"G Nocturne","year":"2013","unstructured":"Nocturne, G. et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sj\u00f6gren's syndrome. Blood 122, 4068\u20134076 (2013).","journal-title":"Blood"},{"key":"BFnrdp201647_CR67","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/ard.2010.144782","volume":"70","author":"E Theander","year":"2011","unstructured":"Theander, E. et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 70, 1363\u20131368 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR68","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/art.39315","volume":"67","author":"G Nocturne","year":"2015","unstructured":"Nocturne, G. et al. CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sj\u00f6gren's syndrome. Arthritis Rheumatol. 67, 3226\u20133233 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR69","doi-asserted-by":"publisher","first-page":"e59868","DOI":"10.1371\/journal.pone.0059868","volume":"8","author":"JE Gottenberg","year":"2013","unstructured":"Gottenberg, J. E. et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sj\u00f6gren's syndrome. Data at enrollment in the prospective ASSESS cohort. PLoS ONE 8, e59868 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrdp201647_CR70","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/rheumatology\/kes180","volume":"52","author":"L Quartuccio","year":"2013","unstructured":"Quartuccio, L. et al. BLyS upregulation in Sj\u00f6gren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands. Rheumatology (Oxford) 52, 276\u2013281 (2013). This is an elegant study that supported the efficacy of blocking BAFF in patients with SjS.","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2013.04.005","volume":"51","author":"A Nezos","year":"2014","unstructured":"Nezos, A. et al. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sj\u00f6gren's syndrome. J. Autoimmun. 51, 89\u201398 (2014).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR72","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1002\/art.27611","volume":"62","author":"GJ Tob\u00f3n","year":"2010","unstructured":"Tob\u00f3n, G. J. et al. The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sj\u00f6gren's syndrome. Arthritis Rheum. 62, 3447\u20133456 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR73","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/sj.bdj.2012.890","volume":"213","author":"AJ Carr","year":"2012","unstructured":"Carr, A. J. et al. Sj\u00f6gren's syndrome \u2014 an update for dental practitioners. Br. Dent. J. 213, 353\u2013357 (2012).","journal-title":"Br. Dent. J."},{"key":"BFnrdp201647_CR74","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","volume":"12","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n, P. et al. Early diagnosis of primary Sj\u00f6gren's syndrome: EULAR-SS Task Force clinical recommendations. Expert Rev. Clin. Immunol. 12, 137\u2013156 (2016). This study notes that patients with SjS can present with systemic manifestations of disease and are at high risk of developing poor outcomes.","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrdp201647_CR75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1601-0825.2012.01930.x","volume":"19","author":"DJ Aframian","year":"2013","unstructured":"Aframian, D. J., Konttinen, Y. T., Carrozzo, M. & Tzioufas, A. G. Urban legends series: Sj\u00f6gren's syndrome. Oral Dis. 19, 46\u201358 (2013).","journal-title":"Oral Dis."},{"key":"BFnrdp201647_CR76","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","volume":"122","author":"EK Akpek","year":"2015","unstructured":"Akpek, E. K. et al. Ocular and systemic morbidity in a longitudinal cohort of Sj\u00f6gren's syndrome. Ophthalmology 122, 56\u201361 (2015).","journal-title":"Ophthalmology"},{"key":"BFnrdp201647_CR77","first-page":"S52","volume":"24","author":"J Albrecht","year":"2006","unstructured":"Albrecht, J. et al. Skin involvement and outcome measures in systemic autoimmune diseases. Clin. Exp. Rheumatol. 24, S52\u2013S59 (2006).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrdp201647_CR78","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2013","unstructured":"Baldini, C. et al. Primary Sj\u00f6gren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology 53, 839\u2013844 (2013).","journal-title":"Rheumatology"},{"key":"BFnrdp201647_CR79","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/rheumatology\/keu271","volume":"53","author":"L Quartuccio","year":"2014","unstructured":"Quartuccio, L. et al. Validation of the classification criteria for cryoglobulinaemic vasculitis. Rheumatology (Oxford) 53, 2209\u20132213 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR80","doi-asserted-by":"publisher","unstructured":"Retamozo, S. et al. Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sj\u00f6gren syndrome: analysis of 515 patients. Rheumatology (Oxford)http:\/\/dx.doi.org\/10.1093\/rheumatology\/kew194 (2016).","DOI":"10.1093\/rheumatology\/kew194"},{"key":"BFnrdp201647_CR81","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror, R. et al. EULAR Sj\u00f6gren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 69, 1103\u20131109 (2010). This study has led to a step forwards in the evaluation of systemic complications of SjS.","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR82","first-page":"349","volume":"32","author":"EJ ter Borg","year":"2014","unstructured":"ter Borg, E. J. & Kelder, J. C. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sj\u00f6gren's syndrome and widespread pain: evidence for a relatively benign subset. Clin. Exp. Rheumatol. 32, 349\u2013353 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrdp201647_CR83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/acr.22720","volume":"68","author":"T Karageorgas","year":"2016","unstructured":"Karageorgas, T. et al. Fatigue in primary Sj\u00f6gren's syndrome: clinical, laboratory, psychometric, and biologic associations. Arthritis Care Res. (Hoboken) 68, 123\u2013131 (2016).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR84","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals, M. et al. Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 54, 2230\u20132238 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR85","first-page":"747","volume":"27","author":"L Riente","year":"2009","unstructured":"Riente, L. et al. Ultrasound imaging for the rheumatologist. XXIII. Sonographic evaluation of hand joint involvement in primary Sj\u00f6gren's syndrome. Clin. Exp. Rheumatol. 27, 747\u2013750 (2009).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrdp201647_CR86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/03009742.2014.923931","volume":"44","author":"L Quartuccio","year":"2015","unstructured":"Quartuccio, L. et al. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sj\u00f6gren's syndrome: results of a large multicentre study. Scand. J. Rheumatol. 44, 36\u201341 (2015).","journal-title":"Scand. J. Rheumatol."},{"key":"BFnrdp201647_CR87","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jcma.2013.11.001","volume":"77","author":"MH Chen","year":"2014","unstructured":"Chen, M. H. et al. Lung involvement in primary Sj\u00f6gren's syndrome: correlation between high-resolution computed tomography score and mortality. J. Chin. Med. Assoc. 77, 75\u201382 (2014).","journal-title":"J. Chin. Med. Assoc."},{"key":"BFnrdp201647_CR88","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.38100","volume":"65","author":"AV Goules","year":"2013","unstructured":"Goules, A. V., Tatouli, I. P., Moutsopoulos, H. M. & Tzioufas, A. G. Clinically significant renal involvement in primary Sj\u00f6gren's syndrome: clinical presentation and outcome. Arthritis Rheum. 65, 2945\u20132953 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR89","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","volume":"53","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals, M. et al. Systemic involvement in primary Sj\u00f6gren's syndrome evaluated by the EULAR-SS Disease Activity Index: analysis of 921 Spanish patients (GEAS-SS registry). Rheumatology (Oxford) 53, 321\u2013331 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR90","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.2004.025676","volume":"64","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals, M., Tzioufas, A. G. & Font, J. Primary Sj\u00f6gren's syndrome: new clinical and therapeutic concepts. Ann. Rheum. Dis. 64, 347\u2013354 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR91","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.39518","volume":"68","author":"G Nocturne","year":"2016","unstructured":"Nocturne, G. et al. Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren's syndrome. Arthritis Rheumatol. 68, 977\u2013985 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR92","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","volume":"73","author":"AP Risselada","year":"2014","unstructured":"Risselada, A. P. et al. The prognostic value of routinely performed minor salivary gland assessments in primary Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 73, 1537\u20131540 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR93","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.autrev.2009.02.027","volume":"8","author":"F Vinagre","year":"2009","unstructured":"Vinagre, F., Santos, M. J., Prata, A., da Silva, J. C. & Santos, A. I. Assessment of salivary gland function in Sj\u00f6gren's syndrome: the role of salivary gland scintigraphy. Autoimmun. Rev. 8, 672\u2013676 (2009).","journal-title":"Autoimmun. Rev."},{"key":"BFnrdp201647_CR94","first-page":"283","volume-title":"Clinical Ocular Pharmacology","author":"JR Paugh","year":"2007","unstructured":"Paugh, J. R. in Clinical Ocular Pharmacology (eds Barlett, J. D. & Jaanus, S. D. ) 283\u2013294 (Butterworth Heinemann, 2007)."},{"key":"BFnrdp201647_CR95","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/acr.22264","volume":"66","author":"E Theander","year":"2014","unstructured":"Theander, E. & Mandl, T. Primary Sj\u00f6gren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system. Arthritis Care Res. (Hoboken) 66, 1102\u20131107 (2014).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR96","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1046\/j.1432-1327.2000.01298.x","volume":"267","author":"G Fabini","year":"2000","unstructured":"Fabini, G., Rutjes, S. A., Zimmermann, C., Pruijn, G. J. & Steiner, G. Analysis of the molecular composition of Ro ribonucleoprotein complexes. Identification of novel Y RNA-binding proteins. Eur. J. Biochem. 267, 2778\u20132789 (2000).","journal-title":"Eur. J. Biochem."},{"key":"BFnrdp201647_CR97","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1093\/rheumatology\/ket295","volume":"52","author":"A Mekinian","year":"2013","unstructured":"Mekinian, A., Nicaise-Roland, P., Chollet-Martin, S., Fain, O. & Crestani, B. Anti-SSA Ro52\/Ro60 antibody testing by immunodot could help the diagnosis of Sj\u00f6gren's syndrome in the absence of anti-SSA\/SSB antibodies by ELISA. Rheumatology (Oxford) 52, 2223\u20132228 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR98","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","volume":"8","author":"J Schulte-Pelkum","year":"2009","unstructured":"Schulte-Pelkum, J., Fritzler, M. & Mahler, M. Latest update on the Ro\/SS-A autoantibody system. Autoimmun. Rev. 8, 632\u2013637 (2009).","journal-title":"Autoimmun. Rev."},{"key":"BFnrdp201647_CR99","first-page":"686","volume":"30","author":"S Retamozo","year":"2012","unstructured":"Retamozo, S. et al. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren's syndrome. Clin. Exp. Rheumatol. 30, 686\u2013692 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrdp201647_CR100","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar3787","volume":"14","author":"A Ambrosi","year":"2012","unstructured":"Ambrosi, A. & Wahren-Herlenius, M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res. Ther. 14, 208 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrdp201647_CR101","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jcla.21545","volume":"26","author":"Z Yang","year":"2012","unstructured":"Yang, Z., Liang, Y. & Zhong, R. Is identification of anti-SSA and\/or -SSB antibodies necessary in serum samples referred for antinuclear antibodies testing? J. Clin. Lab. Anal. 26, 447\u2013451 (2012).","journal-title":"J. Clin. Lab. Anal."},{"key":"BFnrdp201647_CR102","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","volume":"14","author":"L Quartuccio","year":"2015","unstructured":"Quartuccio, L. et al. Anti-SSA\/SSB-negative Sj\u00f6gren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun. Rev. 14, 1019\u20131022 (2015).","journal-title":"Autoimmun. Rev."},{"key":"BFnrdp201647_CR103","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1136\/annrheumdis-2014-206683","volume":"74","author":"AN Baer","year":"2015","unstructured":"Baer, A. N. et al. The SSB-positive\/SSA-negative antibody profile is not associated with key phenotypic features of Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 74, 1557\u20131561 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR104","unstructured":"Danda, D. et al. La positive, Ro60 negative subset of primary Sj\u00f6gren's syndrome is a reality. ACRhttp:\/\/acrabstracts.org\/abstract\/la-positive-ro60-negative-subset-of-primary-sjogrens-syndrome-is-a-reality\/ (2014)."},{"key":"BFnrdp201647_CR105","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals, M., Stone, J. H., Cid, M. C. & Bosch, X. The cryoglobulinaemias. Lancet 379, 348\u2013360 (2012).","journal-title":"Lancet"},{"key":"BFnrdp201647_CR106","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","volume":"51","author":"L Quartuccio","year":"2014","unstructured":"Quartuccio, L. et al. Biomarkers of lymphoma in Sj\u00f6gren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J. Autoimmun. 51, 75\u201380 (2014).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/01.md.0000157398.37679.47","volume":"84","author":"P Brito-Zer\u00f3n","year":"2005","unstructured":"Brito-Zer\u00f3n, P. et al. Circulating monoclonal immunoglobulins in Sj\u00f6gren syndrome. Medicine (Baltimore) 84, 90\u201397 (2005).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrdp201647_CR108","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaut.2012.01.010","volume":"39","author":"P Brito-Zer\u00f3n","year":"2012","unstructured":"Brito-Zer\u00f3n, P. et al. Monoclonal gammopathy related to Sj\u00f6gren syndrome: a key marker of disease prognosis and outcomes. J. Autoimmun. 39, 43\u201348 (2012).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR109","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.autrev.2012.08.001","volume":"12","author":"D Guellec","year":"2013","unstructured":"Guellec, D. et al. Diagnostic value of labial minor salivary gland biopsy for Sj\u00f6gren's syndrome: a systematic review. Autoimmun. Rev. 12, 416\u2013420 (2013).","journal-title":"Autoimmun. Rev."},{"key":"BFnrdp201647_CR110","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/art.30381","volume":"63","author":"TE Daniels","year":"2011","unstructured":"Daniels, T. E. et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sj\u00f6gren's syndrome among 1,726 registry participants. Arthritis Rheum. 63, 2021\u20132030 (2011). This is the largest study describing the different histopathological scenarios that are found in the minor salivary glands of patients with SjS.","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR111","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/rheumatology\/kel266","volume":"46","author":"J Pijpe","year":"2007","unstructured":"Pijpe, J. et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sj\u00f6gren's syndrome. Rheumatology (Oxford) 46, 335\u2013341 (2007).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1034\/j.1600-0714.2001.300102.x","volume":"30","author":"M Vered","year":"2001","unstructured":"Vered, M., Buchner, A., Haimovici, E., Hiss, Y. & Dayan, D. Focal lymphocytic infiltration in aging human palatal salivary glands: a comparative study with labial salivary glands. J. Oral Pathol. Med. 30, 7\u201311 (2001).","journal-title":"J. Oral Pathol. Med."},{"key":"BFnrdp201647_CR113","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/art.10668","volume":"47","author":"L Radfar","year":"2002","unstructured":"Radfar, L., Kleiner, D. E., Fox, P. C. & Pillemer, S. R. Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum. 47, 520\u2013524 (2002).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR114","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","volume":"42","author":"AP Risselada","year":"2013","unstructured":"Risselada, A. P., Looije, M. F., Kruize, A. A., Bijlsma, J. W. & van Roon, J. A. The role of ectopic germinal centers in the immunopathology of primary Sj\u00f6gren's syndrome: a systematic review. Semin. Arthritis Rheum. 42, 368\u2013376 (2013).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrdp201647_CR115","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3899\/jrheum.150058","volume":"42","author":"JH Koh","year":"2015","unstructured":"Koh, J. H., Lee, J., Chung, S.-H., Kwok, S.-K. & Park, S.-H. Relation of autoimmune cytopenia to glandular and systemic manifestations in primary Sj\u00f6gren syndrome: analysis of 113 Korean patients. J. Rheumatol. 42, 1817\u20131824 (2015).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR116","first-page":"726","volume":"31","author":"T Mandl","year":"2004","unstructured":"Mandl, T., Bredberg, A., Jacobsson, L. T. H., Manthorpe, R. & Henriksson, G. CD4+ T-lymphocytopenia \u2014 a frequent finding in anti-SSA antibody seropositive patients with primary Sj\u00f6gren's syndrome. J. Rheumatol. 31, 726\u2013728 (2004).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR117","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","volume":"88","author":"E Baimpa","year":"2009","unstructured":"Baimpa, E., Dahabreh, I. J., Voulgarelis, M. & Moutsopoulos, H. M. Hematologic manifestations and predictors of lymphoma development in primary Sj\u00f6gren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88, 284\u2013293 (2009).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrdp201647_CR118","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali, C. et al. Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group. Ann. Rheum. Dis. 61, 554\u2013558 (2002). This is the \u2018gold-standard\u2019 criteria used worldwide for the diagnosis of SjS.","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR119","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski, S. C. et al. American College of Rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's International Collaborative Clinical Alliance cohort. Arthritis Care Res. (Hoboken) 64, 475\u2013487 (2012).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR120","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.mayocp.2015.03.020","volume":"90","author":"JH Stone","year":"2015","unstructured":"Stone, J. H., Brito-Zer\u00f3n, P., Bosch, X. & Ramos-Casals, M. Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin. Proc. 90, 927\u2013939 (2015).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrdp201647_CR121","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/acr.22216","volume":"66","author":"CP Mavragani","year":"2014","unstructured":"Mavragani, C. P., Fragoulis, G. E., Rontogianni, D., Kanariou, M. & Moutsopoulos, H. M. Elevated IgG4 serum levels among primary Sj\u00f6gren's syndrome patients: do they unmask underlying IgG4-related disease? Arthritis Care Res. (Hoboken) 66, 773\u2013777 (2014).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR122","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1136\/ard.2011.150367","volume":"70","author":"G Nocturne","year":"2011","unstructured":"Nocturne, G. et al. IgG4 multiorgan lymphoproliferative syndrome as a differential diagnosis of primary Sj\u00f6gren's syndrome in men? Ann. Rheum. Dis. 70, 2234\u20132235 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR123","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","volume":"11","author":"P Brito-Zer\u00f3n","year":"2015","unstructured":"Brito-Zer\u00f3n, P., Izmirly, P. M., Ramos-Casals, M., Buyon, J. P. & Khamashta, M. A. The clinical spectrum of autoimmune congenital heart block. Nat. Rev. Rheumatol. 11, 301\u2013312 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrdp201647_CR124","first-page":"652","volume":"108","author":"M Ramos","year":"1997","unstructured":"Ramos, M. et al. [Primary Sj\u00f6gren's syndrome: clinical and immunologic study of 80 patients]. Med. Clin. (Barc.) 108, 652\u2013657 (in Spanish) (1997).","journal-title":"Med. Clin. (Barc.)"},{"key":"BFnrdp201647_CR125","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror, R. et al. Validation of EULAR primary Sj\u00f6gren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann. Rheum. Dis. 74, 859\u2013866 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR126","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror, R. et al. EULAR Sj\u00f6gren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 70, 968\u2013972 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR127","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3899\/jrheum.131527","volume":"41","author":"SJ Johnsen","year":"2014","unstructured":"Johnsen, S. J. et al. Evaluation of germinal center-like structures and B cell clonality in patients with primary Sj\u00f6gren syndrome with and without lymphoma. J. Rheumatol. 41, 2214\u20132222 (2014).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR128","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3899\/jrheum.110077","volume":"38","author":"RPE Pollard","year":"2011","unstructured":"Pollard, R. P. E. et al. Treatment of mucosa-associated lymphoid tissue lymphoma in Sj\u00f6gren's syndrome: a retrospective clinical study. J. Rheumatol. 38, 2198\u20132208 (2011).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR129","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.adaj.2015.11.008","volume":"147","author":"DT Zero","year":"2016","unstructured":"Zero, D. T. et al. Clinical practice guidelines for oral management of Sj\u00f6gren disease: dental caries prevention. J. Am. Dent. Assoc. 147, 295\u2013305 (2016).","journal-title":"J. Am. Dent. Assoc."},{"key":"BFnrdp201647_CR130","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","volume":"8","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals, M., Brito-Zer\u00f3n, P., Sis\u00f3-Almirall, A., Bosch, X. & Tzioufas, A. G. Topical and systemic medications for the treatment of primary Sj\u00f6gren's syndrome. Nat. Rev. Rheumatol. 8, 399\u2013411 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrdp201647_CR131","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.2010.1014","volume":"304","author":"M Ramos-Casals","year":"2010","unstructured":"Ramos-Casals, M., Tzioufas, A. G., Stone, J. H., Siso, A. & Bosch, X. Treatment of primary Sj\u00f6gren syndrome: a systematic review. JAMA 304, 452\u2013460 (2010). This is the first published systematic review that evaluated the use of the main topical and systemic drugs for the treatment of SjS.","journal-title":"JAMA"},{"key":"BFnrdp201647_CR132","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"J-E Gottenberg","year":"2014","unstructured":"Gottenberg, J.-E. et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial. JAMA 312, 249\u2013258 (2014).","journal-title":"JAMA"},{"key":"BFnrdp201647_CR133","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/ard.52.5.360","volume":"52","author":"AA Kruize","year":"1993","unstructured":"Kruize, A. A. et al. Hydroxychloroquine treatment for primary Sj\u00f6gren's syndrome: a two year double blind crossover trial. Ann. Rheum. Dis. 52, 360\u2013364 (1993).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR134","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1136\/ard.2007.083865","volume":"67","author":"S Dass","year":"2008","unstructured":"Dass, S. et al. Reduction of fatigue in Sj\u00f6gren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann. Rheum. Dis. 67, 1541\u20131544 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR135","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer, J. M. et al. Effectiveness of rituximab treatment in primary Sj\u00f6gren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 62, 960\u2013968 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR136","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/M13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec, V. et al. Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial. Ann. Intern. Med. 160, 233\u2013242 (2014).","journal-title":"Ann. Intern. Med."},{"key":"BFnrdp201647_CR137","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/art.21260","volume":"52","author":"J Pijpe","year":"2005","unstructured":"Pijpe, J. et al. Rituximab treatment in patients with primary Sj\u00f6gren's syndrome: an open-label phase II study. Arthritis Rheum. 52, 2740\u20132750 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR138","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","volume":"72","author":"J-E Gottenberg","year":"2013","unstructured":"Gottenberg, J.-E. et al. Efficacy of rituximab in systemic manifestations of primary Sj\u00f6gren's syndrome: results in 78 patients of the autoimmune and rituximab registry. Ann. Rheum. Dis. 72, 1026\u20131031 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR139","doi-asserted-by":"publisher","first-page":"R172","DOI":"10.1186\/ar4359","volume":"15","author":"F Carubbi","year":"2013","unstructured":"Carubbi, F. et al. Efficacy and safety of rituximab treatment in early primary Sj\u00f6gren's syndrome: a prospective, multi-center, follow-up study. Arthritis Res. Ther. 15, R172 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrdp201647_CR140","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1002\/art.24903","volume":"60","author":"J Pijpe","year":"2009","unstructured":"Pijpe, J. et al. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sj\u00f6gren's syndrome. Arthritis Rheum. 60, 3251\u20133256 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR141","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/rheumatology\/kev114","volume":"54","author":"D Cornec","year":"2015","unstructured":"Cornec, D. et al. Development of the Sj\u00f6gren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy. Rheumatology (Oxford) 54, 1699\u20131708 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR142","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/ar2018","volume":"8","author":"SD Steinfeld","year":"2006","unstructured":"Steinfeld, S. D. et al. Epratuzumab (humanised anti-CD22 antibody) in primary Sj\u00f6gren's syndrome: an open-label phase I\/II study. Arthritis Res. Ther. 8, R129 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrdp201647_CR143","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","volume":"74","author":"X Mariette","year":"2015","unstructured":"Mariette, X. et al. Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study. Ann. Rheum. Dis. 74, 526\u2013531 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR144","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/acr.22052","volume":"65","author":"S Adler","year":"2013","unstructured":"Adler, S. et al. Evaluation of histological, serological and clinical changes in response to abatacept treatment of primary Sj\u00f6gren's syndrome: a pilot study. Arthritis Care Res. (Hoboken) 65, 1862\u20131868 (2013).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR145","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","volume":"73","author":"PM Meiners","year":"2014","unstructured":"Meiners, P. M. et al. Abatacept treatment reduces disease activity in early primary Sj\u00f6gren's syndrome (open-label proof of concept ASAP study). Ann. Rheum. Dis. 73, 1393\u20131396 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR146","unstructured":"US National Library of Medicine. Efficacy and safety of abatacept in patients with primary Sj\u00f6gren's syndrome (ASAPIII). ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02067910 (2016)."},{"key":"BFnrdp201647_CR147","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","volume":"381","author":"MJ Rummel","year":"2013","unstructured":"Rummel, M. J. et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 381, 1203\u20131210 (2013).","journal-title":"Lancet"},{"key":"BFnrdp201647_CR148","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/ard.2005.046193","volume":"65","author":"M Voulgarelis","year":"2006","unstructured":"Voulgarelis, M., Giannouli, S., Tzioufas, A. G. & Moutsopoulos, H. M. Long term remission of Sj\u00f6gren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann. Rheum. Dis. 65, 1033\u20131037 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR149","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/rheumatology\/keh170","volume":"43","author":"SJ Bowman","year":"2004","unstructured":"Bowman, S. J. et al. Measurement of fatigue and discomfort in primary Sj\u00f6gren's syndrome using a new questionnaire tool. Rheumatology 43, 758\u2013764 (2004).","journal-title":"Rheumatology"},{"key":"BFnrdp201647_CR150","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/s10165-010-0329-z","volume":"20","author":"V Inal","year":"2010","unstructured":"Inal, V., Kitapcioglu, G., Karabulut, G., Keser, G. & Kabasakal, Y. Evaluation of quality of life in relation to anxiety and depression in primary Sj\u00f6gren's syndrome. Mod. Rheumatol. 20, 588\u2013597 (2010).","journal-title":"Mod. Rheumatol."},{"key":"BFnrdp201647_CR151","first-page":"485","volume":"29","author":"T Hyphantis","year":"2011","unstructured":"Hyphantis, T., Mantis, D., Voulgari, P. V., Tsifetaki, N. & Drosos, A. A. The psychological defensive profile of primary Sj\u00f6gren's syndrome patients and its relationship to health-related quality of life. Clin. Exp. Rheumatol. 29, 485\u2013493 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrdp201647_CR152","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/rheumatology\/37.10.1069","volume":"37","author":"E Thomas","year":"1998","unstructured":"Thomas, E., Hay, E. M., Hajeer, A. & Silman, A. J. Sj\u00f6gren's syndrome: a community-based study of prevalence and impact. Br. J. Rheumatol. 37, 1069\u20131076 (1998).","journal-title":"Br. J. Rheumatol."},{"key":"BFnrdp201647_CR153","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-7-46","volume":"7","author":"B Segal","year":"2009","unstructured":"Segal, B. et al. Primary Sj\u00f6gren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual. Life Outcomes 7, 46 (2009).","journal-title":"Health Qual. Life Outcomes"},{"key":"BFnrdp201647_CR154","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/rheumatology\/kep141","volume":"48","author":"JM Meijer","year":"2009","unstructured":"Meijer, J. M. et al. Health-related quality of life, employment and disability in patients with Sj\u00f6gren's syndrome. Rheumatology (Oxford) 48, 1077\u20131082 (2009).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR155","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/art.21990","volume":"55","author":"J Champey","year":"2006","unstructured":"Champey, J. et al. Quality of life and psychological status in patients with primary Sj\u00f6gren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum. 55, 451\u2013457 (2006).","journal-title":"Arthritis Rheum."},{"key":"BFnrdp201647_CR156","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/rheumatology\/keu361","volume":"54","author":"D Lendrem","year":"2015","unstructured":"Lendrem, D. et al. Do the European League Against Rheumatism Sj\u00f6gren's syndrome outcome measures correlate with health status in primary Sj\u00f6gren's syndrome? Rheumatology (Oxford) 54, 655\u2013659 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR157","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/acr.22632","volume":"68","author":"AN Baer","year":"2016","unstructured":"Baer, A. N., Petri, M., Sohn, J., Rosen, A. & Casciola-Rosen, L. Association of antibodies to interferon-inducible protein-16 with markers of more severe disease in primary Sj\u00f6gren's syndrome. Arthritis Care Res. (Hoboken) 68, 254\u2013260 (2016).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR158","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ICO.0000000000000363","volume":"34","author":"SA Lim","year":"2015","unstructured":"Lim, S. A. et al. Association of IL-21 cytokine with severity of primary Sj\u00f6gren syndrome dry eye. Cornea 34, 248\u2013252 (2015).","journal-title":"Cornea"},{"key":"BFnrdp201647_CR159","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ajpath.2014.09.006","volume":"185","author":"A Iwasa","year":"2015","unstructured":"Iwasa, A. et al. Aromatase controls Sj\u00f6gren syndrome-like lesions through monocyte chemotactic protein-1 in target organ and adipose tissue-associated macrophages. Am. J. Pathol. 185, 151\u2013161 (2015).","journal-title":"Am. J. Pathol."},{"key":"BFnrdp201647_CR160","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fgene.2014.00071","volume":"5","author":"OD Konsta","year":"2014","unstructured":"Konsta, O. D. et al. The contribution of epigenetics in Sj\u00f6gren's syndrome. Front. Genet. 5, 71 (2014).","journal-title":"Front. Genet."},{"key":"BFnrdp201647_CR161","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/annrheumdis-2014-206998","volume":"75","author":"C Miceli-Richard","year":"2016","unstructured":"Miceli-Richard, C. et al. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 75, 933\u2013940 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR162","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/annrheumdis-2015-207509","volume":"75","author":"DF rentino","year":"2016","unstructured":"Fio rentino, D. F. et al. PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sj\u00f6gren's syndrome. Ann. Rheum. Dis. 75, 1145\u20131151(2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR163","doi-asserted-by":"publisher","unstructured":"Bergum, B. et al. Antibodies against carbamylated proteins are present in primary Sj\u00f6gren's syndrome and are associated with disease severity. Ann. Rheum. Dis.http:\/\/dx.doi.org\/10.1136\/annrheumdis-2015-207751 (2015).","DOI":"10.1136\/annrheumdis-2015-207751"},{"key":"BFnrdp201647_CR164","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-015-0750-y","volume":"17","author":"R Seror","year":"2015","unstructured":"Seror, R. et al. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS study. Arthritis Res. Ther. 17, 241 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrdp201647_CR165","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/jop.2015.0017","volume":"31","author":"M Terzulli","year":"2015","unstructured":"Terzulli, M., Ruiz, L. C., Kugadas, A., Masli, S. & Gadjeva, M. TSP-1 deficiency alters ocular microbiota: implications for Sj\u00f6gren's syndrome pathogenesis. J. Ocul. Pharmacol. Ther. 31, 413\u2013418 (2015).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"BFnrdp201647_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2014.02.004","volume":"152","author":"A Szymula","year":"2014","unstructured":"Szymula, A. et al. T cell epitope mimicry between Sj\u00f6gren's syndrome antigen A (SSA)\/Ro60 and oral, gut, skin and vaginal bacteria. Clin. Immunol. 152, 1\u20139 (2014).","journal-title":"Clin. Immunol."},{"key":"BFnrdp201647_CR167","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaut.2015.04.004","volume":"60","author":"B Chaigne","year":"2015","unstructured":"Chaigne, B. et al. Primary Sj\u00f6gren's syndrome and occupational risk factors: a case\u2013control study. J. Autoimmun. 60, 80\u201385 (2015).","journal-title":"J. Autoimmun."},{"key":"BFnrdp201647_CR168","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/art.39059","volume":"67","author":"MP Webber","year":"2015","unstructured":"Webber, M. P. et al. Nested case\u2013control study of selected systemic autoimmune diseases in World Trade Center rescue\/recovery workers. Arthritis Rheumatol. 67, 1369\u20131376 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR169","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.envres.2015.05.007","volume":"140","author":"S Bernatsky","year":"2015","unstructured":"Bernatsky, S. et al. Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta. Environ. Res. 140, 474\u2013478 (2015).","journal-title":"Environ. Res."},{"key":"BFnrdp201647_CR170","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ajo.2015.08.021","volume":"160","author":"J Rose-Nussbaumer","year":"2015","unstructured":"Rose-Nussbaumer, J. et al. Inter-grader agreement of the Ocular Staining Score in the Sj\u00f6gren's International Clinical Collaborative Alliance (SICCA) Registry. Am. J. Ophthalmol. 160, 1150\u20131153.e3 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrdp201647_CR171","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.1167\/iovs.11-8412","volume":"52","author":"M Kaido","year":"2011","unstructured":"Kaido, M. et al. Corneal fluorescein staining correlates with visual function in dry eye patients. Invest. Ophthalmol. Vis. Sci. 52, 9516\u20139522 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrdp201647_CR172","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ajo.2015.09.039","volume":"161","author":"A L\u00f3pez-Miguel","year":"2016","unstructured":"L\u00f3pez-Miguel, A. et al. Clinical and molecular inflammatory response in Sj\u00f6gren syndrome-associated dry eye patients under desiccating stress. Am. J. Ophthalmol. 161, 133\u2013141.e2 (2016).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrdp201647_CR173","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror, R. et al. Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren's syndrome with EULAR primary Sj\u00f6gren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann. Rheum. Dis. 75, 382\u2013389 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrdp201647_CR174","doi-asserted-by":"publisher","unstructured":"Seror, R. et al. Development of clinESSDAI score (clinical EULAR Sj\u00f6gren's Syndrome Disease Activity Index) without the biological domain: a tool for biological studies. Ann. Rheum. Dis.http:\/\/dx.doi.org\/10.1136\/annrheumdis-2015-208504 (2016).","DOI":"10.1136\/annrheumdis-2015-208504"},{"key":"BFnrdp201647_CR175","first-page":"3974","volume":"8","author":"Y-D Ren","year":"2015","unstructured":"Ren, Y.-D. et al. Conventional MRI techniques combined with MR sialography on T2-3D-DRIVE in Sj\u00f6gren syndrome. Int. J. Clin. Exp. Med. 8, 3974\u20133982 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"BFnrdp201647_CR176","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/MD.0000000000000024","volume":"93","author":"J Birnbaum","year":"2014","unstructured":"Birnbaum, J. et al. Use of a novel high-resolution magnetic resonance neurography protocol to detect abnormal dorsal root ganglia in Sj\u00f6gren patients with neuropathic pain: case series of 10 patients and review of the literature. Medicine (Baltimore) 93, 121\u2013134 (2014).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrdp201647_CR177","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.autrev.2013.06.012","volume":"12","author":"C Cohen","year":"2013","unstructured":"Cohen, C. et al. 18F-fluorodeoxyglucose positron emission tomography\/computer tomography as an objective tool for assessing disease activity in Sj\u00f6gren's syndrome. Autoimmun. Rev. 12, 1109\u20131114 (2013).","journal-title":"Autoimmun. Rev."},{"key":"BFnrdp201647_CR178","first-page":"56","volume":"33","author":"DS Hammenfors","year":"2015","unstructured":"Hammenfors, D. S., Brun, J. G., Jonsson, R. & Jonsson, M. V. Diagnostic utility of major salivary gland ultrasonography in primary Sj\u00f6gren's syndrome. Clin. Exp. Rheumatol. 33, 56\u201362 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrdp201647_CR179","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13075-015-0657-7","volume":"17","author":"C Baldini","year":"2015","unstructured":"Baldini, C. et al. Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sj\u00f6gren's syndrome. Arthritis Res. Ther. 17, 146 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrdp201647_CR180","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2006.08.007","volume":"36","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals, M., Brito-Zer\u00f3n, P. & Font, J. The overlap of Sj\u00f6gren's syndrome with other systemic autoimmune diseases. Semin. Arthritis Rheum. 36, 246\u2013255 (2007).","journal-title":"Semin. Arthritis Rheum."},{"key":"BFnrdp201647_CR181","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/1759-7714.12216","volume":"6","author":"Y Xu","year":"2015","unstructured":"Xu, Y. et al. The prevalence and clinical characteristics of primary Sj\u00f6gren's syndrome patients with lung cancer: an analysis of ten cases in China and literature review. Thorac Cancer 6, 475\u2013479 (2015).","journal-title":"Thorac Cancer"},{"key":"BFnrdp201647_CR182","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/acr.22227","volume":"66","author":"M Juarez","year":"2014","unstructured":"Juarez, M. et al. Cardiovascular risk factors in women with primary Sj\u00f6gren's syndrome: United Kingdom primary Sj\u00f6gren's syndrome registry results. Arthritis Care Res. (Hoboken) 66, 757\u2013764 (2014).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"BFnrdp201647_CR183","first-page":"721","volume":"33","author":"Y Atisha-Fregoso","year":"2015","unstructured":"Atisha-Fregoso, Y., Rivera-Vicencio, Y., Ba\u00f1os-Pelaez, M. & Hern\u00e1ndez-Molina, G. Main causes and risk factors for hospitalisation in patients with primary Sj\u00f6gren's syndrome. Clin. Exp. Rheumatol. 33, 721\u2013725 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrdp201647_CR184","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/rheumatology\/kev227","volume":"54","author":"KL Hackett","year":"2015","unstructured":"Hackett, K. L. et al. A systematic review of non-pharmacological interventions for primary Sj\u00f6gren's syndrome. Rheumatology (Oxford) 54, 2025\u20132032 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR185","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1084\/jem.20120994","volume":"209","author":"CS Ma","year":"2012","unstructured":"Ma, C. S., Deenick, E. K., Batten, M. & Tangye, S. G. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209, 1241\u20131253 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnrdp201647_CR186","unstructured":"US National Library of Medicine. Efficacy of tocilizumab in primary Sj\u00f6gren's syndrome. (ETAP). ClinicalTrials.govhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT01782235 (2014)."},{"key":"BFnrdp201647_CR187","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.4049\/jimmunol.1303239","volume":"192","author":"JH Xie","year":"2014","unstructured":"Xie, J. H. et al. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases. J. Immunol. 192, 4083\u20134092 (2014).","journal-title":"J. Immunol."},{"key":"BFnrdp201647_CR188","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/ane.12357","volume":"131","author":"E Signoriello","year":"2015","unstructured":"Signoriello, E., Sagliocchi, A., Fratta, M. & Lus, G. Fingolimod efficacy in multiple sclerosis associated with Sj\u00f6gren syndrome. Acta Neurol. Scand. 131, 140\u2013143 (2015).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrdp201647_CR189","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/RHU.0000000000000210","volume":"21","author":"J Jakez-Ocampo","year":"2015","unstructured":"Jakez-Ocampo, J., Atisha-Fregoso, Y. & Llorente, L. Refractory primary Sj\u00f6gren syndrome successfully treated with bortezomib. J. Clin. Rheumatol. 21, 31\u201332 (2015).","journal-title":"J. Clin. Rheumatol."},{"key":"BFnrdp201647_CR190","first-page":"544","volume":"55","author":"C Oni","year":"2016","unstructured":"Oni, C. et al. Eligibility for clinical trials in primary Sj\u00f6gren's syndrome: lessons from the UK Primary Sj\u00f6gren's Syndrome Registry. Rheumatology (Oxford) 55, 544\u2013552 (2016).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrdp201647_CR191","doi-asserted-by":"publisher","first-page":"e0133907","DOI":"10.1371\/journal.pone.0133907","volume":"10","author":"V Devauchelle-Pensec","year":"2015","unstructured":"Devauchelle-Pensec, V. et al. Which and how many patients should be included in randomised controlled trials to demonstrate the efficacy of biologics in primary Sj\u00f6gren's syndrome? PLoS ONE 10, e0133907 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrdp201647_CR192","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1517\/14712598.2015.1064894","volume":"15","author":"BJ Baum","year":"2015","unstructured":"Baum, B. J., Alevizos, I., Chiorini, J. A., Cotrim, A. P. & Zheng, C. Advances in salivary gland gene therapy \u2014 oral and systemic implications. Expert Opin. Biol. Ther. 15, 1443\u20131454 (2015).","journal-title":"Expert Opin. Biol. Ther."},{"key":"BFnrdp201647_CR193","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000371873","volume":"200","author":"Z Gao","year":"2014","unstructured":"Gao, Z. et al. Generation of bioartificial salivary gland using whole-organ decellularized bioscaffold. Cells Tissues Organs 200, 171\u2013180 (2014).","journal-title":"Cells Tissues Organs"},{"key":"BFnrdp201647_CR194","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrrheum.2015.10","volume":"11","author":"AG Tzioufas","year":"2015","unstructured":"Tzioufas, A. G. & Kapsogeorgou, E. K. Biomarkers. Saliva proteomics is a promising tool to study Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 11, 202\u2013203 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrdp201647_CR195","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/art.39015","volume":"67","author":"N Delaleu","year":"2015","unstructured":"Delaleu, N. et al. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sj\u00f6gren's syndrome. Arthritis Rheumatol. 67, 1084\u20131095 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrdp201647_CR196","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jbspin.2015.02.015","volume":"83","author":"M Le Gall","year":"2016","unstructured":"Le Gall, M. et al. A prospective evaluation of dental and periodontal status in patients with suspected Sj\u00f6gren's syndrome. Joint Bone Spine 83, 235\u2013236 (2016).","journal-title":"Joint Bone Spine"},{"key":"BFnrdp201647_CR197","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3899\/jrheum.141475","volume":"42","author":"R Priori","year":"2015","unstructured":"Priori, R. et al. Quality of sexual life in women with primary Sj\u00f6gren syndrome. J. Rheumatol. 42, 1427\u20131431 (2015).","journal-title":"J. Rheumatol."},{"key":"BFnrdp201647_CR198","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/rheumatology\/keu522","volume":"54","author":"JF van Nimwegen","year":"2015","unstructured":"van Nimwegen, J. F. et al. The impact of primary Sj\u00f6gren's syndrome on female sexual function. Rheumatology 54, 1286\u20131293 (2015).","journal-title":"Rheumatology"},{"key":"BFnrdp201647_CR199","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/0003489415579911","volume":"124","author":"K Tanner","year":"2015","unstructured":"Tanner, K. et al. The quality of life burden associated with voice disorders in Sj\u00f6gren's syndrome. Ann. Otol. Rhinol. Laryngol. 124, 721\u2013727 (2015).","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"BFnrdp201647_CR200","first-page":"6","volume":"29","author":"V Devauchelle-Pensec","year":"2011","unstructured":"Devauchelle-Pensec, V. et al. Effects of rituximab therapy on quality of life in patients with primary Sj\u00f6gren's syndrome. Clin. Exp. Rheumatol. 29, 6\u201312 (2011).","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrdp201647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrdp201647","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrdp201647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:10:59Z","timestamp":1748981459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrdp201647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,22]]}},"alternative-id":["BFnrdp201647"],"URL":"https:\/\/doi.org\/10.1038\/nrdp.2016.47","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]},"assertion":[{"value":"7 July 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16047"}}